Loading…
Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)
Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiet...
Saved in:
Published in: | Journal of medicinal chemistry 1998-07, Vol.41 (14), p.2572-2578 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3 |
---|---|
cites | cdi_FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3 |
container_end_page | 2578 |
container_issue | 14 |
container_start_page | 2572 |
container_title | Journal of medicinal chemistry |
container_volume | 41 |
creator | Jeong, Lak Shin Buenger, Greg McCormack, John J Cooney, David A Hao, Zhang Marquez, Victor E |
description | Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiety of aristeromycin (compound 5), and a newly designed, rigid bicyclo[3.1.0]hexane moiety (compound 6). These three carba-nucleoside versions of zebularine were fashioned to overcome the inherent instability of the parent drug. Each target compound was approached differently using either convergent or linear approaches. The immediate precursor to the cyclopentenyl analogue 4 was obtained by a Mitsunobu coupling of pseudosugar 7 with 2-hydroxypyrimidine. The cyclopentyl analogue 5 was linearly constructed from carbocyclic amine 17, and the final target 6 was similarly constructed from the carbobicyclic amine 27. Of the three target compounds, only 5 showed a significant level of inhibition against human CDA, but it was 16 times less potent than zebularine (K i = 38 μM vs K i(apparent) = 2.3 μM). Although these carbocyclic analogues appeared to be more stable than zebularine, replacement of the electronegative CO4‘ oxygen for the less electronegative carbon in 4−6 presumably reduces the capacity of the pyrimidin-2(1H)-one ring to form a covalent hydrate, a step considered crucial for the compound to function as a transition-state inhibitor of the enzyme. |
doi_str_mv | 10.1021/jm980111x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79986515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17411091</sourcerecordid><originalsourceid>FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3</originalsourceid><addsrcrecordid>eNqFkctu1DAUhiMEKkNhwQMgZQGoI2HwcS6Ol9UU2qJKVKVs2FjHlzAekniwE6lZ9Z14EJ4JVzOaFRKrs_g_fTrn_Fn2Euh7oAw-bHrRUAC4e5QtoGKUlA0tH2cLShkjrGbF0-xZjBtKaQGsOMqORF0B1LDI7lcYlNez7pzOTwfs_I_Jxty3-bi2-bUf7TDmq3l0xg02P7PYuwGjzS-HtVNu9CEHcvLnNzHkxinfTgEHH-duSeAdI8atZxP8dg6ufxAQRnyynHy3auowJOPyefakxS7aF_t5nH379PF2dUGuvpxfrk6vCJa0GUlTMaUqyiwWilrUhgtjFKDSgnJjaWuhtBxbKjgIw3ndMBBQoxZl3aAwxXH2dufdBv8rXTjK3kVtuw4H66couRBN-kn1XxB4CUAFJHC5A3XwMQbbym06E8MsgcqHVuShlcS-2ksn1VtzIPc1pPz1PseosWvTF7WLB4wVrCwZSxjZYS6O9u4QY_gpa17wSt5ef5Xi_DMUNxdC0sS_2fGoo9z4KaR-4z_W-wtx3a_z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17411091</pqid></control><display><type>article</type><title>Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Jeong, Lak Shin ; Buenger, Greg ; McCormack, John J ; Cooney, David A ; Hao, Zhang ; Marquez, Victor E</creator><creatorcontrib>Jeong, Lak Shin ; Buenger, Greg ; McCormack, John J ; Cooney, David A ; Hao, Zhang ; Marquez, Victor E</creatorcontrib><description>Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiety of aristeromycin (compound 5), and a newly designed, rigid bicyclo[3.1.0]hexane moiety (compound 6). These three carba-nucleoside versions of zebularine were fashioned to overcome the inherent instability of the parent drug. Each target compound was approached differently using either convergent or linear approaches. The immediate precursor to the cyclopentenyl analogue 4 was obtained by a Mitsunobu coupling of pseudosugar 7 with 2-hydroxypyrimidine. The cyclopentyl analogue 5 was linearly constructed from carbocyclic amine 17, and the final target 6 was similarly constructed from the carbobicyclic amine 27. Of the three target compounds, only 5 showed a significant level of inhibition against human CDA, but it was 16 times less potent than zebularine (K i = 38 μM vs K i(apparent) = 2.3 μM). Although these carbocyclic analogues appeared to be more stable than zebularine, replacement of the electronegative CO4‘ oxygen for the less electronegative carbon in 4−6 presumably reduces the capacity of the pyrimidin-2(1H)-one ring to form a covalent hydrate, a step considered crucial for the compound to function as a transition-state inhibitor of the enzyme.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm980111x</identifier><identifier>PMID: 9651161</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Analytical, structural and metabolic biochemistry ; Animals ; aristeromycin ; Biological and medical sciences ; Cytidine - analogs & derivatives ; cytidine deaminase ; Cytidine Deaminase - antagonists & inhibitors ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Enzymes and enzyme inhibitors ; Fundamental and applied biological sciences. Psychology ; Humans ; Hydrolases ; Mice ; Pyrimidine Nucleosides - chemical synthesis ; Pyrimidine Nucleosides - chemistry ; Pyrimidine Nucleosides - pharmacology ; Structure-Activity Relationship ; zebularine</subject><ispartof>Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2572-2578</ispartof><rights>Copyright © 1998 American Chemical Society</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3</citedby><cites>FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2324422$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9651161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jeong, Lak Shin</creatorcontrib><creatorcontrib>Buenger, Greg</creatorcontrib><creatorcontrib>McCormack, John J</creatorcontrib><creatorcontrib>Cooney, David A</creatorcontrib><creatorcontrib>Hao, Zhang</creatorcontrib><creatorcontrib>Marquez, Victor E</creatorcontrib><title>Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiety of aristeromycin (compound 5), and a newly designed, rigid bicyclo[3.1.0]hexane moiety (compound 6). These three carba-nucleoside versions of zebularine were fashioned to overcome the inherent instability of the parent drug. Each target compound was approached differently using either convergent or linear approaches. The immediate precursor to the cyclopentenyl analogue 4 was obtained by a Mitsunobu coupling of pseudosugar 7 with 2-hydroxypyrimidine. The cyclopentyl analogue 5 was linearly constructed from carbocyclic amine 17, and the final target 6 was similarly constructed from the carbobicyclic amine 27. Of the three target compounds, only 5 showed a significant level of inhibition against human CDA, but it was 16 times less potent than zebularine (K i = 38 μM vs K i(apparent) = 2.3 μM). Although these carbocyclic analogues appeared to be more stable than zebularine, replacement of the electronegative CO4‘ oxygen for the less electronegative carbon in 4−6 presumably reduces the capacity of the pyrimidin-2(1H)-one ring to form a covalent hydrate, a step considered crucial for the compound to function as a transition-state inhibitor of the enzyme.</description><subject>Analytical, structural and metabolic biochemistry</subject><subject>Animals</subject><subject>aristeromycin</subject><subject>Biological and medical sciences</subject><subject>Cytidine - analogs & derivatives</subject><subject>cytidine deaminase</subject><subject>Cytidine Deaminase - antagonists & inhibitors</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hydrolases</subject><subject>Mice</subject><subject>Pyrimidine Nucleosides - chemical synthesis</subject><subject>Pyrimidine Nucleosides - chemistry</subject><subject>Pyrimidine Nucleosides - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>zebularine</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkctu1DAUhiMEKkNhwQMgZQGoI2HwcS6Ol9UU2qJKVKVs2FjHlzAekniwE6lZ9Z14EJ4JVzOaFRKrs_g_fTrn_Fn2Euh7oAw-bHrRUAC4e5QtoGKUlA0tH2cLShkjrGbF0-xZjBtKaQGsOMqORF0B1LDI7lcYlNez7pzOTwfs_I_Jxty3-bi2-bUf7TDmq3l0xg02P7PYuwGjzS-HtVNu9CEHcvLnNzHkxinfTgEHH-duSeAdI8atZxP8dg6ufxAQRnyynHy3auowJOPyefakxS7aF_t5nH379PF2dUGuvpxfrk6vCJa0GUlTMaUqyiwWilrUhgtjFKDSgnJjaWuhtBxbKjgIw3ndMBBQoxZl3aAwxXH2dufdBv8rXTjK3kVtuw4H66couRBN-kn1XxB4CUAFJHC5A3XwMQbbym06E8MsgcqHVuShlcS-2ksn1VtzIPc1pPz1PseosWvTF7WLB4wVrCwZSxjZYS6O9u4QY_gpa17wSt5ef5Xi_DMUNxdC0sS_2fGoo9z4KaR-4z_W-wtx3a_z</recordid><startdate>19980702</startdate><enddate>19980702</enddate><creator>Jeong, Lak Shin</creator><creator>Buenger, Greg</creator><creator>McCormack, John J</creator><creator>Cooney, David A</creator><creator>Hao, Zhang</creator><creator>Marquez, Victor E</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>19980702</creationdate><title>Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)</title><author>Jeong, Lak Shin ; Buenger, Greg ; McCormack, John J ; Cooney, David A ; Hao, Zhang ; Marquez, Victor E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Analytical, structural and metabolic biochemistry</topic><topic>Animals</topic><topic>aristeromycin</topic><topic>Biological and medical sciences</topic><topic>Cytidine - analogs & derivatives</topic><topic>cytidine deaminase</topic><topic>Cytidine Deaminase - antagonists & inhibitors</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hydrolases</topic><topic>Mice</topic><topic>Pyrimidine Nucleosides - chemical synthesis</topic><topic>Pyrimidine Nucleosides - chemistry</topic><topic>Pyrimidine Nucleosides - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>zebularine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jeong, Lak Shin</creatorcontrib><creatorcontrib>Buenger, Greg</creatorcontrib><creatorcontrib>McCormack, John J</creatorcontrib><creatorcontrib>Cooney, David A</creatorcontrib><creatorcontrib>Hao, Zhang</creatorcontrib><creatorcontrib>Marquez, Victor E</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jeong, Lak Shin</au><au>Buenger, Greg</au><au>McCormack, John J</au><au>Cooney, David A</au><au>Hao, Zhang</au><au>Marquez, Victor E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1998-07-02</date><risdate>1998</risdate><volume>41</volume><issue>14</issue><spage>2572</spage><epage>2578</epage><pages>2572-2578</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiety of aristeromycin (compound 5), and a newly designed, rigid bicyclo[3.1.0]hexane moiety (compound 6). These three carba-nucleoside versions of zebularine were fashioned to overcome the inherent instability of the parent drug. Each target compound was approached differently using either convergent or linear approaches. The immediate precursor to the cyclopentenyl analogue 4 was obtained by a Mitsunobu coupling of pseudosugar 7 with 2-hydroxypyrimidine. The cyclopentyl analogue 5 was linearly constructed from carbocyclic amine 17, and the final target 6 was similarly constructed from the carbobicyclic amine 27. Of the three target compounds, only 5 showed a significant level of inhibition against human CDA, but it was 16 times less potent than zebularine (K i = 38 μM vs K i(apparent) = 2.3 μM). Although these carbocyclic analogues appeared to be more stable than zebularine, replacement of the electronegative CO4‘ oxygen for the less electronegative carbon in 4−6 presumably reduces the capacity of the pyrimidin-2(1H)-one ring to form a covalent hydrate, a step considered crucial for the compound to function as a transition-state inhibitor of the enzyme.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>9651161</pmid><doi>10.1021/jm980111x</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2572-2578 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_79986515 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Analytical, structural and metabolic biochemistry Animals aristeromycin Biological and medical sciences Cytidine - analogs & derivatives cytidine deaminase Cytidine Deaminase - antagonists & inhibitors Enzyme Inhibitors - chemical synthesis Enzyme Inhibitors - chemistry Enzyme Inhibitors - pharmacology Enzymes and enzyme inhibitors Fundamental and applied biological sciences. Psychology Humans Hydrolases Mice Pyrimidine Nucleosides - chemical synthesis Pyrimidine Nucleosides - chemistry Pyrimidine Nucleosides - pharmacology Structure-Activity Relationship zebularine |
title | Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbocyclic%20Analogues%20of%20the%20Potent%20Cytidine%20Deaminase%20Inhibitor%201-(%CE%B2-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one%20(Zebularine)&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Jeong,%20Lak%20Shin&rft.date=1998-07-02&rft.volume=41&rft.issue=14&rft.spage=2572&rft.epage=2578&rft.pages=2572-2578&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm980111x&rft_dat=%3Cproquest_cross%3E17411091%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17411091&rft_id=info:pmid/9651161&rfr_iscdi=true |